ArticleBMC cancer2025

The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma.

Ruifeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.